First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors
First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors
Recruiting · NCT05828459 · Registry updated 2025-03-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Recruiting | Phase 1 | 2025-03-20 | NCT05828459 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Onward Therapeutics | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Eugène Marquis | Rennes | France | 37 |
| Icm - Montpellier | Montpellier | France | 2 |
| Saint-Eloi Hospital - Montpellier (CHU) | Montpellier | France | 1 |
| Saint-Joseph Hospital - Paris | Paris | France | 1 |